FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/069774 [Registered on: 01/07/2024] Trial Registered Prospectively
Last Modified On: 29/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   To study the effect of vidangadi lepa and tiktaka ghrita in the management of psoriasis  
Scientific Title of Study   Etiopathological study of ekakustha w.s.r to psoriasis and effect of vidangadi lepa and tiktaka ghrita 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Padmaja Rani Panda 
Designation  P G Scholar 
Affiliation  Govt Ayurvedic College And Hospital Balangir 
Address  Post Graduate Department of Roga Nidana Evam Vikriti Vigyana Govt Ayurvedic college and Hospital Balangir

Balangir
ORISSA
767001
India 
Phone  7749086320  
Fax    
Email  padmajaranipanda47@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Padmaja Rani Panda 
Designation  P G Scholar 
Affiliation  Govt Ayurvedic College And Hospital Balangir 
Address  Post Graduate Department of Roga Nidana Evam Vikriti Vigyana Govt Ayurvedic college and Hospital Balangir


ORISSA
767001
India 
Phone  7749086320  
Fax    
Email  padmajaranipanda47@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Padmaja Rani Panda 
Designation  P G Scholar 
Affiliation  Govt Ayurvedic College And Hospital Balangir 
Address  Post Graduate Department of Roga Nidana Evam Vikriti Vigyana Govt Ayurvedic college and Hospital Balangir


ORISSA
767001
India 
Phone  7749086320  
Fax    
Email  padmajaranipanda47@gmail.com  
 
Source of Monetary or Material Support  
Govt Ayurvedic College and Hospital Balangir 767001 Odisha India 
 
Primary Sponsor  
Name  Dr Padmaja Rani Panda 
Address  Post Graduate Department of Roga Nidana Evam Vikrit Vigyana Govt Ayurvedic College and Hospital Balangir ODISHA 767001 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Utkalini Nayak  Govt Ayurvedic College and Hospital Balangir  OPD & IPD of Post Graduate Department of Roga Nidana Evam Vikriti Vigyana Balangir ORISSA
Balangir
ORISSA 
8658483032

utkalini2006@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee Goverment Ayurvedic College and Hospital Balangir  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L409||Psoriasis, unspecified. Ayurveda Condition: EKAKUSHTHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Tiktaka Ghrita, Reference: Chakradatta, Route: Oral, Dosage Form: Ghrita, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -luke warm water), Additional Information: -
2Intervention ArmProcedure-lepa, लेप (Procedure Reference: Chakradutta, Procedure details: Take vidanga paste & apply it on affected area twice in a day for 30 days)
(1) Medicine Name: Vidangadi lepa, Reference: Chakradutta, Route: Topical, Dosage Form: Kalka/ Paste, Dose: 10(g), Frequency: bd, Duration: 30 Days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Patients who fulfill the diagnostic criteria of both Eka kustha and Psoriasis and Psoriasis without secondary infection 
 
ExclusionCriteria 
Details  Patients are less than 20 years and more than 50 years of age Patients with any systemic diseases Patients having RA & ASO positive Patients having signs & symptoms of other skin diseases 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduction of sign and symptoms like auspitzs sign candle grease sign reduction of sweating and patches  30 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in Mental & Physical health along with development in Pasi score  30 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is an etiopathological study of Eka kustha  and its Management with Vidangadi lepa and Tiktaka Ghrita w. s. r to Psoriasis. This is done compulsory part of Post Graduate Course. Total No. of Patients to be studied is 30 with duration of 30 days. 
Close